Our Scientific Applications Support team has assembled a list of frequently asked questions to help you find answers quickly. Filter using one or more categories to focus on specific topics, or use the search bar to perform a text search.
2’MOE and Affinity Plus modified bases are often included in ASOs, in addition to phosphorothioate bonds. 2’MOE modified bases help to increase nuclease resistance and binding affinity and decrease toxicity of the ASO. Affinity Plus bases are locked nucleic acid bases that also help to increase binding affinity and nuclease resistance but can be toxic.
2’MOE bases are often incorporated into ASOs in a 5-10-5 gapmer format, with five 2’MOE bases, ten DNA bases, and five 2’MOE bases. Affinity Plus bases are typically used in shorter ASOs in a 3-10-3 gapmer format (three Affinity Plus bases, ten DNA bases, three Affinity Plus bases). The shorter length of Affinity Plus ASOs is beneficial when delivering the ASO in vivo without a delivery tool.
*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.